Lindsay A. Abraham, JD, CIP
Regulatory Chair Director
Biography
Lindsay Abraham, JD, CIP, is a regulatory chair director at WCG’s IRB and has over 13 years of experience in the clinical research field, specifically the IRB space.
Lindsay chairs Board meetings and provides guidance to the Board and clients regarding the interpretation of federal and state laws pertaining to IRB operations and functions. Lindsay also presents education and training courses for Board members and staff.
Prior to joining WCG in 2010, Lindsay practiced in the field of family law and holds a Juris Doctorate from Seattle University School of Law.
Latest insights by Lindsay
Questions on the FDA’s 30-Day IND Review Period and IRB Approval
Blog Posts
Series: Ask the IRB & IBC Experts
Is it possible to make a PI’s name or institution confidential on a consent form?
Blog Posts
Ethics in Clinical Research
If a Subject’s Care Is Divided Equally Between Two Caregivers, Who Should Sign Caregiver Consent?
Blog Posts
Clinical Trial Safety
Do we need to submit safety events from another site to our IRB?
Blog Posts
FDA & ICH
What are the IRB submission requirements for observational studies?
Blog Posts
FDA & ICH